Compare · CTCX vs MDLN
CTCX vs MDLN
Side-by-side comparison of Carmell Corporation (CTCX) and Medline Inc. (MDLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CTCX and MDLN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN carries a market cap of $48.08B.
- MDLN has hit the wire 7 times in the past 4 weeks while CTCX has been quiet.
- MDLN has more recent analyst coverage (25 ratings vs 0 for CTCX).
- Company
- Carmell Corporation
- Medline Inc.
- Price
- $0.20+5.08%
- $35.95-1.74%
- Market cap
- -
- $48.08B
- 1M return
- -
- +11.97%
- 1Y return
- -
- -11.77%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- 2025
- News (4w)
- 0
- 7
- Recent ratings
- 0
- 25
Latest CTCX
- SEC Form 424B3 filed by Carmell Corporation
- Carmell Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- SEC Form 424B3 filed by Carmell Corporation
- Carmell Corporation filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits
- CARMELL CORP REBRANDS AS LONGEVITY HEALTH HOLDINGS TO HIGHLIGHT BUSINESS FOCUS & GROWTH STRATEGY
- SEC Form 424B3 filed by Carmell Corporation
- Carmell Corporation filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
- SEC Form 424B3 filed by Carmell Corporation
- SEC Form EFFECT filed by Carmell Corporation
- SEC Form DEF 14A filed by Carmell Corporation
Latest MDLN
- SEC Form 8-K filed by Medline Inc.
- Medline to build Midwestern network with new 800,000-square-foot facility in Van Buren Township, Mich.
- SEC Form 4 filed by Medline Inc.
- Medline launches enhanced TrackPoint™ to simplify inventory management for post-acute care
- SEC Form 4 filed by Medline Inc.
- MEDLINE INC. MDLN INVESTORS: Contact Kirby McInerney LLP About the Firm’s Securities Investigation Following 12.8% Share Drop
- Medline to report third quarter 2026 results on November 4, 2026
- INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Medline Inc. to Contact Law Firm
- Medline announces participation in the Morgan Stanley 24th Annual Global Healthcare Conference
- SEC Form 4 filed by Chief Executive Officer Boyle James M